VEGFA and diabetic retinopathy: Inhibition of TNFα release, along with inhibition of VEGF signaling in diabetic retinopathy, has already been described in diabetic rats treated with intravitreal injection of aflibercept [54], likely involving the extracellular signal-regulated kinase (ERK) pathway.